PubMed Health⌕ Search

Biomedical subjects

E Farley

Publications and source records attributed to E Farley.

5 recordsLinked to original sources

Voices from family medicine: Eugene Farley. Interview by William B. Ventres and John J. Frey.

This transcript is an abridged and edited version of interviews conducted with Eugene Farley, MD, MPH, in May 1991. It is the second in a series that looks into both the founding history of family medicine and the lives of those people who helped create the discipline. Dr. Farley is professor and chair of the Department of Family Medicine and Practice at the University of Wisconsin. In 1989, he received the STFM Recognition Award.

Family Practice↗

High-dose intensity systemic therapy of metastatic bladder cancer.

Forty-three consecutively diagnosed patients with widely metastatic transitional cell carcinoma of the bladder (TCCB) were treated with a high-dose intensity, chronobiologically timed combination of doxorubicin and cisplatin, followed by Cytoxan (Mead Johnson Pharmaceuticals, Evansville, IN), 5-fluorouracil (5-FU), and cisplatin maintenance for up to 2 years. Fifty-seven percent of the 35 evaluable patients with widespread metastatic cancer responded objectively. Twenty-three percent had complete disappearance of all cancer. Median survival from first treatment for complete responders (CRs) was more than 2 years, and 1 year for partial responders (PRs). Three of the CRs were alive without evidence of cancer more than 2 years after stopping all therapy. High-dose intensity combination chemotherapy can induce durable CRs of widespread bladder cancer.

Aged↗